NPPA fixes retail price of 84 formulations, Details
New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has fixed the retail price of 84 new drugs including those used to lower the levels of triglycerides in blood, to prevent heart attack and stroke, to treat high blood pressure, type 2 diabetes, and gastro-oesophageal reflux disease.
These include Theon Pharmaceuticals, Cadila Pharmaceuticals' Ceftriaxone & Tazobactam for Injection, Pure and Cure Healthcare,Cipla's Atorvastatin and Fenofibrate Tablets, Aishwarya Healthcare,Torrent Pharmaceuticals' Budesonide & Formoterol Fumarate Respirator Suspension, Hema Laboratories,Abbott Healthcare's Ofloxacin and Metronidazole suspension.
The list further includes popular antidiabetic medicines such as Sun Pharma's Dapagliflozin and metformin Hydrochloride (IR) Tablets, Exemed Pharmaceuticals,Cipla's Dapagliflozin & Metformin Hydrochloride Extended Release Tablets, Alkem's Sitagliptin and Metformin Hydrochloride (as extended release) Tablets, Exemed Pharmaceuticals, Zydus Healthcare's Sitagliptin and Metformin Hydrochloride (as extended release) Tablets, Exemed Pharmaceuticals,Glenmark Pharma's Sitagliptin and Metformin Hydrochloride (as extended release) Tablets, etc.
This comes after in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), has fixed, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof,
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
1. | Voglibose and (SR) Metformin Hydrochloride Tablet | Each uncoated bilayered tablet contains: Voglibose IP 0.3mg Metformin Hydrochloride IP 500mg (As Sustained Release Form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 10.47 |
2. | Olmesartan Medoxomil, Amlodipine & Hydrochlorothiaz ide Tablet | Each film coated tablet contains: Olmesartan Medoxomil 20mg Amlodipine Besilate IP eq. to Amlodipine 5mg Hydrochlorothiazide IP 12.5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 12.91 |
3. | Hydroxychloroqu ine Sulphate Tablet | Each film coated tablet contains: Hydroxychloroquine Sulphate IP 300 mg | 1 Tablet | M/s Hetero Healthcare Ltd. | 11.74 |
4. | Linezolid for Oral Suspension (combipack with Steril Water) | Each Combi pack Contains:
Each 5 ml of Constituted Suspension Contains : Linezolid IP 100 mg
Each Vial Contains : Sterile water for Injection IP 30 ml | Per Combi Pack | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Eris Healthcare Pvt. limited | 102.00 |
5. | Paracetamol and Caffeine Tablets | Each uncoated tablet contains: Paracetamol IP 650mg Caffeine Anhydrous IP 50mg | 1 Tablet | M/s Rivpra Formulation Pvt. Ltd. / M/s Dabur India Ltd. | 2.88 |
6. | Paracetamol & | Each 5ml contains: | 1 ML | M/s Bioconic | 0.33 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Ibuprofen Suspension | Paracetamol IP 162.50mg Ibuprofen IP 100mg | Remedies. / M/s Dales Laboratories Pvt. Ltd. | |||
7. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in Sustained Release form), Glimepiride IP 1mg Voglibose IP 0.2mg Tablets | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences / M/s Sun Pharmaceutical Industries Limited | 11.43 |
8. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in Sustained Release form), Glimepiride IP 2mg Voglibose IP 0.2mg Tablets | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences / M/s Sun Pharmaceutical Industries Limited | 13.30 |
9. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in Sustained Release form), Glimepiride IP 1mg Voglibose IP 0.2mg Tablets | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences / M/s Sun Pharma Laboratories Limited | 11.43 |
10. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (in Sustained Release form), Glimepiride IP 2mg Voglibose IP 0.2mg Tablets | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences / M/s Sun Pharma Laboratories Limited | 13.30 |
11. | Sucralfate & Oxetacaine Oral Suspension | Each 10ml contains: Sucralfate IP 1gm Oxetacaine BP 20mg | 1 ML | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 1.76 |
12. | Rosuvastatin, Aspirin & Clopidogrel Capsule | Each Hard Gelatin Capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 10mg (as film coated tablet) Aspirin IP 75mg (as Gastro- resistant tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as film coated tablet) | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 13.91 |
13. | Rosuvastatin, Aspirin & Clopidogrel Capsule | Each Hard Gelatin Capsule contains: Rosuvastatin Calcium IP eq. to Rosuvastatin 20mg (as film coated tablet) Aspirin IP 75mg (as Gastro- resistant tablet) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (as film | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 20.27 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
coated tablet) | |||||
14. | Glimepiride, Pioglitazone Hydrochloride & Metformin Hydrochloride (SR) Tablet | Each uncoated bilayered tablet contains: Glimepiride IP 1 mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Sustained Release Form) | 1 Tablet | M/s Akum Drugs & Pharmaceuticals Limited/M/s German Remedies Pharmaceuticals Pvt. Ltd. | 8.03 |
15. | Glimepiride, Pioglitazone Hydrochloride & Metformin Hydrochloride (SR) Tablet | Each uncoated bilayered tablet contains: Glimepiride IP 2 mg Pioglitazone Hydrochloride IP eq. to Pioglitazone 15 mg Metformin Hydrochloride IP 500 mg (In Sustained Release Form) | 1 Tablet | M/s Akum Drugs & Pharmaceuticals Limited/M/s German Remedies Pharmaceuticals Pvt. Ltd. | 11.10 |
16. | Amoxycillin & Potassium Clavulanate Tablets IP | Each film coated tablet contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 875mg Potassium Clavulanate Diluted eq. to Clavulanic Acid IP 125mg | 1 Tablet | M/s Medicef Pharma /M/s Themis Medicare Limited | 34.03 |
17. | Amoxycillin & Potassium Clavulanate Oral Suspension | Each 5ml of reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 400mg Potassium Clavulanate Diluted eq. to Clavulanic Acid IP 57mg Steril water for injection 30ml | 1 ML | M/s Medicef Pharma M/s Themis Medicare Limited | 3.90 |
18. | Paracetamol & Thiocolchicoside Tablet | Each uncoated tablet contains: Paracetamol IP 500 mg Thiocolchicoside IP 8 mg | 1 Tablet | M/s Micro Labs Limited | 27.90 |
19. | Ferrous Ascorbate and Folic Acid Oral Drops | Each ml contains: Ferrous Ascorbate IP eq. to Elemental Iron 10mg Folic Acid IP 100mcg | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 5.06 |
20. | Ferrous Ascorbate and Folic Acid Suspension IP | Each 5 ml contains: Ferrous Ascorbate IP eq. to Elemental Iron 30mg Folic Acid IP 500mcg | 1 ML | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 0.87 |
21. | Amlodipine and Telmisartan tablets | Each uncoated bilayered tablet contains: Amlodipine Besilate IP eq. to Amlodipine 5mg Telmisartan IP 80mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 17.33 |
22. | Amlodipine and Telmisartan tablets | Each uncoated bilayered tablet contains: Amlodipine Besilate IP eq. to Amlodipine 5mg Telmisartan IP 40mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Pvt. Ltd. / M/s German Remedies Pharmaceuticals | 9.76 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Private Limited | |||||
23. | Clopidogrel & Aspirin Tablets | Each uncoated / film coated bilayered tablet contains: Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg Aspirin IP 150mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 4.34 |
24. | Aceclofenac, Paracetamol & Trypsin Chymotrypsin Tablets | Each enteric coated tablet contains: Proteolytic enzymes Trypsin & Chymotrypsin In the ratio of Approximately 6:1 and provides enzymatic activity eq. to 150000 Armour Units Aceclofenac IP 100mg Paracetamol IP 325mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Ipca Laboratories Limited | 13.85 |
25. | Ferrous Ascorbate, Folic Acid & Zinc Tablets | Each film coated tablet contains: Ferrous Ascorbate IP eq. to Elemental Iron 100mg Folic Acid IP 1.5mg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 22.5mg | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 9.65 |
26. | Calcium Carbonate, Calcitriol & Zinc Capsules | Each soft Gelatin Capsule contains: Calcium Carbonate IP 500mg eq. to Elemental Calcium 200mg Calcitriol IP 0.25mcg Zinc Sulphate Monohydrate IP eq. to Elemental Zinc 7.5mg | 1 Capsule | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 14.07 |
27. | Cilnidipine & Telmisartan Tablets | Each film coated tablet contains Cilnidipine IP 10 mg Telmisartan IP 40 mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Troikaa Pharmaceuticals Limited | 9.92 |
28. | Cilnidipine, Telmisartan & Metoprolol (ER) Tablets | Each film coated bilayered tablet contains Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol SuccinateIP 23.75mg eq. to Metoprolol Tartrate 25mg (as extended release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Troikaa Pharmaceuticals Limited | 10.24 |
29. | Cilnidipine, Telmisartan & Metoprolol (ER) Tablets | Each film coated bilayered tablet contains Telmisartan IP 40 mg Cilnidipine IP 10 mg Metoprolol SuccinateIP 47.50mg eq. to Metoprolol Tartrate 50mg (as extended release) | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. / M/s Troikaa Pharmaceuticals Limited | 12.77 |
30. | Ceftriaxone & Tazobactam for Injection | Each vial contains: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000mg Sterile Tazobactam Sodium IP eq. to Tazobactam 125mg | Per Vial | M/s Theon Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Ltd. | 168.43 |
31. | Ceftriaxone & | Each vial contains: | Per Vial | M/s Skymap | 168.43 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Tazobactam Injection | Ceftriaxone Sodium IP (Sterile) eq. to anhydrous Ceftriaxone 1000mg Tazobactam Sodium IP (Sterile) eq. to Anhydrous Tazobactam 125mg | Healthcare Pvt. Ltd. | |||
32. | Diclofenac Injection IP | Each ml contains: Diclofenac Sodium IP 75mg water for Injection | 1 ML | M/s Nichepharm Lifesciences Pvt. Ltd. / M/s Cipla Ltd. | 20.72 |
33. | Atorvastatin and Fenofibrate Tablets | Each film coated tablet contains: Atorvastatin Calcium IP eq. to Atorvastatin 10mg Fenofibrate IP (Micronized) 160mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Cipla Ltd. | 13.87 |
34. | Budesonide & Formoterol Fumarate Respirator Suspension | Each 2ml contains: Budesonide IP 0.5mg Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumaret 20mcg | 1 ML | M/s Aishwarya Healthcare / M/s Torrent Pharmaceuticals Ltd. | 22.75 |
35. | Ceftriaxone & Sulbactam water for injection | Each vial contains : Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000mg, Sterile Sulbactam Sodium IP eq. to Sulbactam 500mg Each ampoule contains: Sterile water for injection IP 10ml | Per Pack | M/s Inject Care Parenterals Pvt. Ltd. / Torrent Pharmaceuticals Ltd. | 143.52 |
36. | Ceftriaxone & Tazobactam for Injection 1125mg | Each Combipack Contains: Part-I Each vial contains : Ceftriaxone Sodium IP (Sterile) eq. to Ceftriaxone 1gm, Tazobactam Sodium Sterile eq. to Tazobactam (Sterile) 125mg Part-II (For Reconstitution) Each FFS Ampoule contains: Sterile Water for Injection IP 10ml | Per Pack | M/s Nitin Lifesciences Limited / M/s Softdeal Pharmaceutical Private Limited | 168.43 |
37. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (In Sustained Release form) Glimepiride IP 1mg Voglibose IP 0.2mg | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 11.43 |
38. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (In Sustained Release formm) Glimepiride IP 2mg Voglibose IP 0.2mg | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 13.85 |
39. | Rabeprazole Sodium (gastro- resistant) & Domperidone | Each hard gelatin capsule contains: Rabeprazole Sodium IP 40mg (as reddish brown coloured | 1 Capsule | M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd. | 10.83 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
(SR) Capsules | enteric coated pellets) Domperidone IP 30mg (as orange coloured sustained release pellets) | ||||
40. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (In Sustained Release form) Glimepiride IP 2mg Voglibose IP 0.2mg | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 13.85 |
41. | Metformin Hydrochloride (SR), Glimepiride and Voglibose Tablets | Each uncoated bilayered tablet contains: Metformin Hydrochloride IP 1000mg (In Sustained Release form) Glimepiride IP 1mg Voglibose IP 0.2mg | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 11.43 |
42. | Sitagliptin Phosphate & Metformin Hydrochloride Tablets | Each Film Coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500 mg | 1 Tablet | M/s Alembic Pharmaceuticals Limited | 16.96 |
43. | Sitagliptin Phosphate & Metformin Hydrochloride Tablets | Each Film Coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000 mg | 1 Tablet | M/s Alembic Pharmaceuticals Limited | 18.75 |
44. | Sitagliptin and Metformin Hydrochloride SR Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Akums drugs & Pharmaceuticals Limited / M/s Abbott Healthcare Pvt. Ltd. | 20.06 |
45. | Sitagliptin and Metformin Hydrochloride SR Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Akums drugs & Pharmaceuticals Limited / M/s Abbott Healthcare Pvt. Ltd. | 18.34 |
46. | Sitagliptin and Metformin Hydrochloride SR Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Akums drugs & Pharmaceuticals Limited / M/s Abbott Healthcare Pvt. Ltd. | 19.81 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
47. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Torrent Pharmaceuticals Limited | 18.34 |
48. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 850mg | 1 Tablet | M/s Torrent Pharmaceuticals Limited | 19.14 |
49. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Torrent Pharmaceuticals Limited | 20.02 |
50. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 18.34 |
51. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. | 20.02 |
52. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd. | 18.34 |
53. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Skymap Pharmaceuticals Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd. | 20.02 |
54. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Micro Labs limited | 18.34 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
55. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Micro Labs limited | 20.00 |
56. | Sitagliptin and Metformin Hydrochloride (SR) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg (as sustained release form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited | 20.06 |
57. | Sitagliptin and Metformin Hydrochloride (SR) Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg (as sustained release form) | 1 Tablet | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Zydus Healthcare Limited | 18.67 |
58. | Sitagliptin and Metformin Hydrochloride (extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP (In extended release form) 500mg | 1 Tablet | M/s Zydus Healthcare Limited | 20.17 |
59. | Sitagliptin and Metformin Hydrochloride (extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP (In extended release form) 1000mg | 1 Tablet | M/s Zydus Healthcare Limited | 21.56 |
60. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP (as extended release form) 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Glenmark Pharmaceuticals Limited | 20.17 |
61. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP (as extended release form) 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Glenmark Pharmaceuticals Limited | 21.56 |
62. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited | 21.56 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Metformin Hydrochloride IP (as extended release form) 1000mg | |||||
63. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s FDC Limited | 10.41 |
64. | Sitagliptin and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Synokem Pharmaceuticals Limited / M/s FDC Limited | 8.92 |
65. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride IP (as extended release form) 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Emcure Pharmaceuticals Limited | 20.17 |
66. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 eq. to Sitagliptin 50mg Metformin Hydrochloride IP 500mg | 1 Tablet | M/s Unison Pharmaceuticals Pvt. Limited | 18.34 |
67. | Sitagliptin and Metformin Hydrochloride (extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 18.67 |
68. | Sitagliptin and Metformin Hydrochloride (extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 20.06 |
69. | Sitagliptin and Metformin Hydrochloride (extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 100mg Metformin Hydrochloride (As Extended Release) IP 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 20.17 |
70. | Sitagliptin and Metformin Hydrochloride (extended | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited | 21.56 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
release) Tablets | 100mg Metformin Hydrochloride IP (As Extended Release form) 1000mg | ||||
71. | Sitagliptin Phosphate and Metformin Hydrochloride Tablets | Each film coated tablet contains: Sitagliptin Phosphate Monohydrate IP 64.25 eq. to Sitagliptin 50mg Metformin Hydrochloride IP 1000mg | 1 Tablet | M/s Unison Pharmaceuticals Pvt. Limited | 20.02 |
72. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 500mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited | 18.67 |
73. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 1000mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Zydus Healthcare Limited | 20.06 |
74. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 500mg | 1 Tablet | M/s Alkem Healthscience (A unit of Alkem Laboratories Ltd.) M/s Alkem Laboratories Ltd. | 18.67 |
75. | Sitagliptin and Metformin Hydrochloride (as extended release) Tablets | Each film coated bilayered tablet contains: Sitagliptin Phosphate IP eq. to Sitagliptin 50mg Metformin Hydrochloride IP (As Extended Release form) 1000mg | 1 Tablet | M/s Alkem Healthscience (A unit of Alkem Laboratories Ltd.)/ M/s Alkem Laboratories Ltd. | 20.06 |
76. | Medroxyprogest erone Acetate SR Tablets | Each uncoated sustained release tablet contains: Medroxyprogesterone Acetate IP 30mg | 1 Tablet | M/s Synokem Pharmaceuticals Ltd. / M/s Obsurge Biotech Ltd. | 14.04 |
77. | Cefixime and Potassium Clavulanate Oral Suspension | Each 5ml of the reconstituted suspension contains: Cefixime (As Trihydrate) IP eq. to Anhydrous Cefixime 50mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 31.25mg | 1 ML | M/s Prosperity Drugs Pvt. Ltd. / M/s Intas Pharmaceuticals Ltd. | 2.70 |
78. | Diclofenac, Virgin Linseed Oil, Methyl Salicylate, Menthol & Capsaicin Gel | Composition: Diclofenac Diethylamine IP 1.16%w/w (eq. to Diclofenac Sodium 1%w/w), Virgin Linseed Oil BP 3%w/w (Containing Predominantly | 1 Gram | M/s Akums Drugs & Pharmaceuticals Ltd. / M/s German Remedies Pharmaceuticals Private Limited | 3.12 |
Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
(1) | (2) | (3) | (4) | (5) | (6) |
Alpha Linolenic Acid), Methyl Salicylate IP 10% w/w Menthol IP 5%w/w Capsaicin USP 0.025% w/w | |||||
79. | Ofloxacin and Metronidazole suspension | Each 5ml contains: Ofloxacin IP 50mg Metronidazole Benzoate IP eq. to Metronidazole 100mg | 1 ML | M/s Hema Laboratories Pvt. Ltd. / M/s Abbott Healthcare Pvt. Ltd. | 0.70 |
80. | Dapagliflozin and metformin Hydrochloride (IR) Tablets | Each film coated tablet contains: Dapagliflozin propanediol monohydrate eq. to Dapagliflozin 5mg Metformin Hydrochloride IP 500mg (as Immediate release form) | 1 Tablet | M/s Sun Pharma Laboratories Limited | 6.25 |
81. | Dapagliflozin & Metformin Hydrochloride Extended Release Tablets | Each film coated tablet contains: Metformin Hydrochloride…500mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 5mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 6.25 |
82. | Dapagliflozin & Metformin Hydrochloride Extended Release Tablets | Each film coated tablet contains: Metformin Hydrochloride…1000mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 5mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 7.23 |
83. | Dapagliflozin & Metformin Hydrochloride Extended Release Tablets | Each film coated tablet contains: Metformin Hydrochloride…500mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 10mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 9.21 |
84. | Dapagliflozin & Metformin Hydrochloride Extended Release Tablets | Each film coated tablet contains: Metformin Hydrochloride…1000mg (as extended release form) Dapagliflozin Propanediol Monohydrate eq to Dapagliflozin 10mg | 1 Tablet | M/s Exemed Pharmaceuticals / M/s Cipla Ltd. | 10.69 |
The notice further added,
(a) The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
